Axsome Therapeutics Inc (AXSM)
74.16
-0.73
(-0.97%)
USD |
NASDAQ |
May 02, 16:00
74.17
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Profit Margin (Quarterly): -137.9% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -137.9% |
| September 30, 2023 | -107.6% |
| June 30, 2023 | -143.8% |
| March 31, 2023 | -11.86% |
| Date | Value |
|---|---|
| December 31, 2022 | -251.3% |
| September 30, 2022 | -266.1% |
| June 30, 2022 | -469.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-469.8%
Minimum
Jun 2022
-11.86%
Maximum
Mar 2023
-198.3%
Average
-143.8%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 9.36% |
| Vertex Pharmaceuticals Inc | 38.48% |
| Krystal Biotech Inc | 20.62% |
| Alnylam Pharmaceuticals Inc | -31.35% |
| Catalyst Pharmaceuticals Inc | 31.51% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -124.5% |
| Return on Assets | -47.44% |
| Return on Invested Capital | -68.95% |
| Gross Profit Margin (Quarterly) | 89.69% |
| Operating Margin (Quarterly) | -76.98% |
| Return on Net Operating Assets | -162.8% |